EVLO (Evelo Biosciences) Float Percentage Of Total Shares Outstanding: 46.68% (As of Jun. 28, 2026)


What is Evelo Biosciences Float Percentage Of Total Shares Outstanding?

Evelo Biosciences EVLO -99.00% Float Percentage Of Total Shares Outstanding is 46.68% as of Jun. 28, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Evelo Biosciences's float shares is 8.86 Mil. Evelo Biosciences's total shares outstanding is 18.98 Mil. Evelo Biosciences's float percentage of total shares outstanding is 46.68%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Evelo Biosciences's Insider Ownership is 2.81%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Evelo Biosciences's Institutional Ownership is 0.14%.

Evelo Biosciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Evelo Biosciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=8.86/18.98
=46.68%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 46.68% mean?
Evelo Biosciences (EVLO) has a Float Percentage Of Total Shares Outstanding of 46.68% as of Jun. 28, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Evelo Biosciences and its competitors.
Is Evelo Biosciences' Float Percentage Of Total Shares Outstanding too high?
Evelo Biosciences' current Float Percentage Of Total Shares Outstanding is 46.68%.
How does Evelo Biosciences' Float Percentage Of Total Shares Outstanding compare to IMNN and EDSA?
Evelo Biosciences' Float Percentage Of Total Shares Outstanding of 46.68% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Evelo Biosciences and its competitors. Evelo Biosciences's current Float Percentage Of Total Shares Outstanding is 46.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current Float Percentage Of Total Shares Outstanding of 46.68%. The current Float Percentage Of Total Shares Outstanding is 46.68%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current Float Percentage Of Total Shares Outstanding is 46.68% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.